Supplying the latest research on the formulation, manufacture, quality control, and regulation of pharmaceuticals, biopharmaceuticals, and related products, this reference contains up-to-the-minute chapters on contamination control, facilities management, inspection, distribution, GMP, sterility and stability testing, and aseptic environments.
Supplying the latest research on the formulation, manufacture, quality control, and regulation of pharmaceuticals, biopharmaceuticals, and related products, this reference contains up-to-the-minute chapters on contamination control, facilities management, inspection, distribution, GMP, sterility and stability testing, and aseptic environments.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Michael J. Akers Ph.D. is Senior Director of Pharmaceutical Research and Development at Baxter and leads the Baxter Lyophilization Center of Excellence in Bloomington, Indiana. Dr. Akers received his B.A. degree from Wabash College and Ph.D. degree in Pharmaceutics from the University of Iowa College of Pharmacy, and has previously been employed at Searle Laboratories, Alcon Laboratories, University of Tennessee, and Eli Lilly and Company. Dr. Akers is active in the Parenteral Drug Association and is a Fellow of the American Association of Pharmaceutical Scientists. He is editor-in-chief of Pharmaceutical Development and Technology, and author or editor of six books, including Parenteral Quality Control: Sterility, Pyrogen, Particulate, and Packaging Integrity Testing, Third Edition, 2002.
Inhaltsangabe
Introduction, scope, and history of sterile productsCharacteristics of sterile dosage formsTypes of sterile dosage formsSterile product packaging systemsOverview of product developmentFormulation components (solvents and solutes)Sterile products packaging chemistryFormulation and stability of solutionsDispersed systemsFormulation of freeze-dried powdersOvercoming formulation problems and some case studiesOverview of sterile product manufacturingContamination controlSterile manufacturing facilitiesWater and air quality in sterile manufacturing facilitiesPersonnel requirements for sterile manufacturingSterilization methods in sterile product manufacturing Sterile filtrationSterile product filling, stoppering, and sealing Freeze-dry (lyophilization) processingAseptic processingInspection, labeling, and secondary packagingBarrier and other advanced technologies in aseptic processingStability, storage, and distribution of sterile drug productsGood manufacturing practiceQuality assurance and control Microorganisms and sterility testingPyrogens and pyrogen/endotoxin testing Particles and particulate matter testingSterile product-package integrity testingAdministration of injectable drug productsClinical hazards of injectable drug administrationBiopharmaceutical considerations with injectable drug delivery
Introduction, scope, and history of sterile productsCharacteristics of sterile dosage formsTypes of sterile dosage formsSterile product packaging systemsOverview of product developmentFormulation components (solvents and solutes)Sterile products packaging chemistryFormulation and stability of solutionsDispersed systemsFormulation of freeze-dried powdersOvercoming formulation problems and some case studiesOverview of sterile product manufacturingContamination controlSterile manufacturing facilitiesWater and air quality in sterile manufacturing facilitiesPersonnel requirements for sterile manufacturingSterilization methods in sterile product manufacturing Sterile filtrationSterile product filling, stoppering, and sealing Freeze-dry (lyophilization) processingAseptic processingInspection, labeling, and secondary packagingBarrier and other advanced technologies in aseptic processingStability, storage, and distribution of sterile drug productsGood manufacturing practiceQuality assurance and control Microorganisms and sterility testingPyrogens and pyrogen/endotoxin testing Particles and particulate matter testingSterile product-package integrity testingAdministration of injectable drug productsClinical hazards of injectable drug administrationBiopharmaceutical considerations with injectable drug delivery
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
